<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Diabetic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> (DbCM), which consists of <z:mp ids='MP_0001625'>cardiac hypertrophy</z:mp> and failure in the absence of traditional risk factors, is a major contributor to increased <z:hpo ids='HP_0001635'>heart failure</z:hpo> risk in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:e sem="disease" ids="C1519106" disease_type="Experimental Model of Disease" abbrv="">rodent models</z:e> of DbCM, <z:mp ids='MP_0001625'>cardiac hypertrophy</z:mp> and dysfunction have been shown to depend upon <z:chebi fb="4" ids="26607">saturated fatty acid</z:chebi> (SFA) oversupply and de novo <z:chebi fb="0" ids="26739">sphingolipid</z:chebi> synthesis </plain></SENT>
<SENT sid="2" pm="."><plain>However, it is not known whether these effects are mediated by bulk SFAs and <z:chebi fb="0" ids="26739">sphingolipids</z:chebi> or by individual <z:chebi fb="23" ids="18059">lipid</z:chebi> species </plain></SENT>
<SENT sid="3" pm="."><plain>In this report, we demonstrate that a diet high in SFA induced <z:mp ids='MP_0001625'>cardiac hypertrophy</z:mp>, left ventricular systolic and diastolic dysfunction, and autophagy in mice </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, treatment with the SFA <z:chebi fb="0" ids="30807">myristate</z:chebi>, but not <z:chebi fb="2" ids="29889">palmitate</z:chebi>, induced <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> and autophagy in adult primary cardiomyocytes </plain></SENT>
<SENT sid="5" pm="."><plain>De novo <z:chebi fb="0" ids="26739">sphingolipid</z:chebi> synthesis was required for induction of <z:hpo ids='HP_0000001'>all</z:hpo> pathological features observed both in vitro and in vivo, and autophagy was required for induction of <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> in vitro </plain></SENT>
<SENT sid="6" pm="."><plain>Finally, we implicated a specific <z:chebi fb="7" ids="17761">ceramide</z:chebi> N-acyl chain length in this process and demonstrated a requirement for (dihydro)<z:chebi fb="7" ids="17761">ceramide</z:chebi> synthase 5 in cardiomyocyte autophagy and <z:chebi fb="0" ids="30807">myristate</z:chebi>-mediated <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, this report reveals a requirement for a specific <z:chebi fb="0" ids="26739">sphingolipid</z:chebi> metabolic route and dietary SFAs in the molecular pathogenesis of lipotoxic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> and <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> </plain></SENT>
</text></document>